US Patent 7501415 Selective inhibitors of ERK protein kinase and uses thereof

Patent 7501415 was granted and assigned to Vertex Pharmaceuticals on March, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Vertex Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7501415

Date of Patent

March 10, 2009

Patent Application Number

11312618

Date Filed

December 20, 2005

Patent Citations Received

‌

US Patent 11980633 Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors

Patent Primary Examiner

‌

Deepak Rao

Patent abstract

Described herein are compounds that are useful as ERK2 inhibitors. These compounds, and pharmaceutically acceptable compositions thereof, are useful for treating or lessening the severity of a variety of disorders, including proliferative disorders such as cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7501415 Selective inhibitors of ERK protein kinase and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API